{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:41:28Z","timestamp":1786545688108,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.14309\/crj.2015.74","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T15:32:18Z","timestamp":1436801538000},"page":"247-249","source":"Crossref","is-referenced-by-count":6,"title":["Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon \u03b1-2a and Ribavirin for Chronic Hepatitis C"],"prefix":"10.14309","volume":"2","author":[{"given":"Chetan","family":"Rathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav","family":"Pipaliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Choksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pathik","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghraj","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabha","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 2","key":"R1-100-20210317","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1478-3231.2011.02539.x","article-title":"A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.","volume":"31","author":"Cornberg","year":"2011","journal-title":"Liver Int"},{"issue":"suppl 1","key":"R2-100-20210317","first-page":"2","article-title":"2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.","volume":"32","year":"2012","journal-title":"Liver Int"},{"issue":"4","key":"R3-100-20210317","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: An update.","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"R4-100-20210317","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0972-9747.58803","article-title":"Flares on and off therapy during chronic HBV infection: Pathogenesis, significance and management.","volume":"5","author":"Amarapurkar","year":"2008","journal-title":"Hep B Annual"},{"issue":"2","key":"R5-100-20210317","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis.","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"R6-100-20210317","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/0016-5085(95)90139-6","article-title":"Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C.","volume":"108","author":"Garcia-Buey","year":"1995","journal-title":"Gastroenterology"},{"issue":"12","key":"R7-100-20210317","doi-asserted-by":"crossref","first-page":"A20","DOI":"10.1016\/S1542-3565(04)00446-X","article-title":"Induction of autoimmune hepatitis by pegylated interferon alpha-2b in chronic hepatitis C.","volume":"2","author":"Lorke","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"R8-100-20210317","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5799\/ahinjs.02.2012.03.0056","article-title":"The acute hepatic flare in a patient with chronic hepatitis C infection receiving pegylated interferon alpha 2b and ribavirin.","volume":"2","author":"Demiraslan","year":"2012","journal-title":"J Microbiol Infect Dis"},{"issue":"9","key":"R9-100-20210317","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1478-3231.2006.01345.x","article-title":"Anti-golgi complex antibodies during pegylated-interferon therapy for hepatitis C.","volume":"26","author":"Parana","year":"2006","journal-title":"Liver Int"}],"container-title":["ACG Case Reports Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02075970-201502000-00100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:45:12Z","timestamp":1786542312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02075970-201502000-00100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.14309\/crj.2015.74","relation":{},"ISSN":["2326-3253"],"issn-type":[{"value":"2326-3253","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}